nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A4—Rivastigmine—Alzheimer's disease	0.182	0.432	CbGbCtD
Alfentanil—CYP3A4—Donepezil—Alzheimer's disease	0.146	0.345	CbGbCtD
Alfentanil—CYP3A4—Galantamine—Alzheimer's disease	0.094	0.223	CbGbCtD
Alfentanil—Movement disorder—Rivastigmine—Alzheimer's disease	0.0179	0.0401	CcSEcCtD
Alfentanil—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.0106	0.0237	CcSEcCtD
Alfentanil—Myoclonus—Memantine—Alzheimer's disease	0.0092	0.0206	CcSEcCtD
Alfentanil—Myoclonus—Rivastigmine—Alzheimer's disease	0.009	0.0201	CcSEcCtD
Alfentanil—Hiccups—Galantamine—Alzheimer's disease	0.00787	0.0176	CcSEcCtD
Alfentanil—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00731	0.0164	CcSEcCtD
Alfentanil—Apnoea—Memantine—Alzheimer's disease	0.00653	0.0146	CcSEcCtD
Alfentanil—Apnoea—Rivastigmine—Alzheimer's disease	0.00639	0.0143	CcSEcCtD
Alfentanil—Dyskinesia—Memantine—Alzheimer's disease	0.00589	0.0132	CcSEcCtD
Alfentanil—Dyskinesia—Rivastigmine—Alzheimer's disease	0.00576	0.0129	CcSEcCtD
Alfentanil—Hiccups—Rivastigmine—Alzheimer's disease	0.00541	0.0121	CcSEcCtD
Alfentanil—Euphoric mood—Donepezil—Alzheimer's disease	0.00524	0.0117	CcSEcCtD
Alfentanil—Disorientation—Memantine—Alzheimer's disease	0.00449	0.01	CcSEcCtD
Alfentanil—Epistaxis—Galantamine—Alzheimer's disease	0.00415	0.00928	CcSEcCtD
Alfentanil—Bradycardia—Galantamine—Alzheimer's disease	0.00402	0.00899	CcSEcCtD
Alfentanil—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00388	0.00868	CcSEcCtD
Alfentanil—Cardiac arrest—Memantine—Alzheimer's disease	0.00382	0.00854	CcSEcCtD
Alfentanil—Visual impairment—Galantamine—Alzheimer's disease	0.00381	0.00851	CcSEcCtD
Alfentanil—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00374	0.00836	CcSEcCtD
Alfentanil—Eye disorder—Galantamine—Alzheimer's disease	0.00369	0.00825	CcSEcCtD
Alfentanil—Cardiac disorder—Galantamine—Alzheimer's disease	0.00367	0.0082	CcSEcCtD
Alfentanil—Angiopathy—Galantamine—Alzheimer's disease	0.00358	0.00801	CcSEcCtD
Alfentanil—Immune system disorder—Galantamine—Alzheimer's disease	0.00357	0.00798	CcSEcCtD
Alfentanil—Arrhythmia—Galantamine—Alzheimer's disease	0.00353	0.00789	CcSEcCtD
Alfentanil—Mental disorder—Galantamine—Alzheimer's disease	0.00346	0.00774	CcSEcCtD
Alfentanil—Bronchospasm—Memantine—Alzheimer's disease	0.00342	0.00764	CcSEcCtD
Alfentanil—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00334	0.00747	CcSEcCtD
Alfentanil—Vision blurred—Galantamine—Alzheimer's disease	0.00324	0.00724	CcSEcCtD
Alfentanil—Epistaxis—Donepezil—Alzheimer's disease	0.00322	0.00719	CcSEcCtD
Alfentanil—Agitation—Galantamine—Alzheimer's disease	0.00316	0.00706	CcSEcCtD
Alfentanil—Bradycardia—Donepezil—Alzheimer's disease	0.00312	0.00697	CcSEcCtD
Alfentanil—Drowsiness—Rivastigmine—Alzheimer's disease	0.00303	0.00677	CcSEcCtD
Alfentanil—Loss of consciousness—Galantamine—Alzheimer's disease	0.00302	0.00676	CcSEcCtD
Alfentanil—Cough—Galantamine—Alzheimer's disease	0.003	0.00671	CcSEcCtD
Alfentanil—Convulsion—Galantamine—Alzheimer's disease	0.00298	0.00666	CcSEcCtD
Alfentanil—Hypertension—Galantamine—Alzheimer's disease	0.00297	0.00664	CcSEcCtD
Alfentanil—Visual impairment—Donepezil—Alzheimer's disease	0.00295	0.0066	CcSEcCtD
Alfentanil—Epistaxis—Memantine—Alzheimer's disease	0.00292	0.00653	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00291	0.0065	CcSEcCtD
Alfentanil—Epistaxis—Rivastigmine—Alzheimer's disease	0.00286	0.00639	CcSEcCtD
Alfentanil—Confusional state—Galantamine—Alzheimer's disease	0.00283	0.00633	CcSEcCtD
Alfentanil—Bradycardia—Memantine—Alzheimer's disease	0.00283	0.00633	CcSEcCtD
Alfentanil—Bradycardia—Rivastigmine—Alzheimer's disease	0.00277	0.00619	CcSEcCtD
Alfentanil—Nervous system disorder—Galantamine—Alzheimer's disease	0.00275	0.00615	CcSEcCtD
Alfentanil—Chills—Donepezil—Alzheimer's disease	0.00275	0.00614	CcSEcCtD
Alfentanil—Tachycardia—Galantamine—Alzheimer's disease	0.00274	0.00612	CcSEcCtD
Alfentanil—Arrhythmia—Donepezil—Alzheimer's disease	0.00273	0.00611	CcSEcCtD
Alfentanil—Connective tissue disorder—Memantine—Alzheimer's disease	0.00273	0.00611	CcSEcCtD
Alfentanil—Skin disorder—Galantamine—Alzheimer's disease	0.00273	0.00609	CcSEcCtD
Alfentanil—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00271	0.00606	CcSEcCtD
Alfentanil—Mental disorder—Donepezil—Alzheimer's disease	0.00268	0.006	CcSEcCtD
Alfentanil—Visual impairment—Memantine—Alzheimer's disease	0.00268	0.00599	CcSEcCtD
Alfentanil—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00267	0.00597	CcSEcCtD
Alfentanil—Erythema—Donepezil—Alzheimer's disease	0.00266	0.00596	CcSEcCtD
Alfentanil—Hypotension—Galantamine—Alzheimer's disease	0.00262	0.00586	CcSEcCtD
Alfentanil—Visual impairment—Rivastigmine—Alzheimer's disease	0.00262	0.00586	CcSEcCtD
Alfentanil—Eye disorder—Memantine—Alzheimer's disease	0.0026	0.00581	CcSEcCtD
Alfentanil—Cardiac disorder—Memantine—Alzheimer's disease	0.00258	0.00577	CcSEcCtD
Alfentanil—Eye disorder—Rivastigmine—Alzheimer's disease	0.00254	0.00568	CcSEcCtD
Alfentanil—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00252	0.00564	CcSEcCtD
Alfentanil—Angiopathy—Memantine—Alzheimer's disease	0.00252	0.00564	CcSEcCtD
Alfentanil—Vision blurred—Donepezil—Alzheimer's disease	0.00251	0.00561	CcSEcCtD
Alfentanil—Immune system disorder—Memantine—Alzheimer's disease	0.00251	0.00561	CcSEcCtD
Alfentanil—Mediastinal disorder—Memantine—Alzheimer's disease	0.0025	0.0056	CcSEcCtD
Alfentanil—Somnolence—Galantamine—Alzheimer's disease	0.00249	0.00558	CcSEcCtD
Alfentanil—Chills—Memantine—Alzheimer's disease	0.00249	0.00558	CcSEcCtD
Alfentanil—Arrhythmia—Memantine—Alzheimer's disease	0.00248	0.00555	CcSEcCtD
Alfentanil—Angiopathy—Rivastigmine—Alzheimer's disease	0.00247	0.00552	CcSEcCtD
Alfentanil—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00245	0.00548	CcSEcCtD
Alfentanil—Agitation—Donepezil—Alzheimer's disease	0.00245	0.00547	CcSEcCtD
Alfentanil—Chills—Rivastigmine—Alzheimer's disease	0.00244	0.00545	CcSEcCtD
Alfentanil—Mental disorder—Memantine—Alzheimer's disease	0.00243	0.00544	CcSEcCtD
Alfentanil—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00243	0.00543	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00242	0.00542	CcSEcCtD
Alfentanil—Fatigue—Galantamine—Alzheimer's disease	0.00242	0.00541	CcSEcCtD
Alfentanil—Mental disorder—Rivastigmine—Alzheimer's disease	0.00238	0.00533	CcSEcCtD
Alfentanil—Erythema—Rivastigmine—Alzheimer's disease	0.00237	0.00529	CcSEcCtD
Alfentanil—Loss of consciousness—Donepezil—Alzheimer's disease	0.00234	0.00524	CcSEcCtD
Alfentanil—Cough—Donepezil—Alzheimer's disease	0.00233	0.0052	CcSEcCtD
Alfentanil—Feeling abnormal—Galantamine—Alzheimer's disease	0.00231	0.00517	CcSEcCtD
Alfentanil—Convulsion—Donepezil—Alzheimer's disease	0.00231	0.00516	CcSEcCtD
Alfentanil—Hypertension—Donepezil—Alzheimer's disease	0.0023	0.00514	CcSEcCtD
Alfentanil—Vision blurred—Memantine—Alzheimer's disease	0.00228	0.0051	CcSEcCtD
Alfentanil—Vision blurred—Rivastigmine—Alzheimer's disease	0.00223	0.00499	CcSEcCtD
Alfentanil—Agitation—Memantine—Alzheimer's disease	0.00222	0.00497	CcSEcCtD
Alfentanil—Body temperature increased—Galantamine—Alzheimer's disease	0.00222	0.00496	CcSEcCtD
Alfentanil—Confusional state—Donepezil—Alzheimer's disease	0.00219	0.0049	CcSEcCtD
Alfentanil—Agitation—Rivastigmine—Alzheimer's disease	0.00217	0.00486	CcSEcCtD
Alfentanil—Nervous system disorder—Donepezil—Alzheimer's disease	0.00213	0.00477	CcSEcCtD
Alfentanil—Loss of consciousness—Memantine—Alzheimer's disease	0.00213	0.00475	CcSEcCtD
Alfentanil—Cough—Memantine—Alzheimer's disease	0.00211	0.00472	CcSEcCtD
Alfentanil—Hyperhidrosis—Donepezil—Alzheimer's disease	0.0021	0.0047	CcSEcCtD
Alfentanil—Convulsion—Memantine—Alzheimer's disease	0.0021	0.00469	CcSEcCtD
Alfentanil—Hypertension—Memantine—Alzheimer's disease	0.00209	0.00467	CcSEcCtD
Alfentanil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00208	0.00465	CcSEcCtD
Alfentanil—Hypersensitivity—Galantamine—Alzheimer's disease	0.00207	0.00462	CcSEcCtD
Alfentanil—Cough—Rivastigmine—Alzheimer's disease	0.00207	0.00462	CcSEcCtD
Alfentanil—Convulsion—Rivastigmine—Alzheimer's disease	0.00205	0.00458	CcSEcCtD
Alfentanil—Hypertension—Rivastigmine—Alzheimer's disease	0.00204	0.00457	CcSEcCtD
Alfentanil—Hypotension—Donepezil—Alzheimer's disease	0.00203	0.00454	CcSEcCtD
Alfentanil—Asthenia—Galantamine—Alzheimer's disease	0.00201	0.0045	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.002	0.00447	CcSEcCtD
Alfentanil—Confusional state—Memantine—Alzheimer's disease	0.00199	0.00445	CcSEcCtD
Alfentanil—Confusional state—Rivastigmine—Alzheimer's disease	0.00195	0.00435	CcSEcCtD
Alfentanil—Nervous system disorder—Memantine—Alzheimer's disease	0.00194	0.00433	CcSEcCtD
Alfentanil—Somnolence—Donepezil—Alzheimer's disease	0.00193	0.00432	CcSEcCtD
Alfentanil—Tachycardia—Memantine—Alzheimer's disease	0.00193	0.00431	CcSEcCtD
Alfentanil—Skin disorder—Memantine—Alzheimer's disease	0.00192	0.00429	CcSEcCtD
Alfentanil—Hyperhidrosis—Memantine—Alzheimer's disease	0.00191	0.00427	CcSEcCtD
Alfentanil—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00189	0.00424	CcSEcCtD
Alfentanil—Tachycardia—Rivastigmine—Alzheimer's disease	0.00189	0.00421	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00188	0.0042	CcSEcCtD
Alfentanil—Skin disorder—Rivastigmine—Alzheimer's disease	0.00188	0.00419	CcSEcCtD
Alfentanil—Fatigue—Donepezil—Alzheimer's disease	0.00187	0.00419	CcSEcCtD
Alfentanil—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00187	0.00417	CcSEcCtD
Alfentanil—Pain—Donepezil—Alzheimer's disease	0.00186	0.00416	CcSEcCtD
Alfentanil—Dizziness—Galantamine—Alzheimer's disease	0.00186	0.00415	CcSEcCtD
Alfentanil—Hypotension—Memantine—Alzheimer's disease	0.00184	0.00413	CcSEcCtD
Alfentanil—Hypotension—Rivastigmine—Alzheimer's disease	0.0018	0.00404	CcSEcCtD
Alfentanil—Feeling abnormal—Donepezil—Alzheimer's disease	0.00179	0.00401	CcSEcCtD
Alfentanil—Vomiting—Galantamine—Alzheimer's disease	0.00178	0.00399	CcSEcCtD
Alfentanil—Rash—Galantamine—Alzheimer's disease	0.00177	0.00396	CcSEcCtD
Alfentanil—Dermatitis—Galantamine—Alzheimer's disease	0.00177	0.00395	CcSEcCtD
Alfentanil—Headache—Galantamine—Alzheimer's disease	0.00176	0.00393	CcSEcCtD
Alfentanil—Somnolence—Memantine—Alzheimer's disease	0.00176	0.00392	CcSEcCtD
Alfentanil—Urticaria—Donepezil—Alzheimer's disease	0.00173	0.00386	CcSEcCtD
Alfentanil—Body temperature increased—Donepezil—Alzheimer's disease	0.00172	0.00384	CcSEcCtD
Alfentanil—Somnolence—Rivastigmine—Alzheimer's disease	0.00172	0.00384	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0017	0.00381	CcSEcCtD
Alfentanil—Fatigue—Memantine—Alzheimer's disease	0.0017	0.00381	CcSEcCtD
Alfentanil—Pain—Memantine—Alzheimer's disease	0.00169	0.00378	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00167	0.00373	CcSEcCtD
Alfentanil—Nausea—Galantamine—Alzheimer's disease	0.00167	0.00373	CcSEcCtD
Alfentanil—Fatigue—Rivastigmine—Alzheimer's disease	0.00167	0.00372	CcSEcCtD
Alfentanil—Pain—Rivastigmine—Alzheimer's disease	0.00165	0.00369	CcSEcCtD
Alfentanil—Feeling abnormal—Memantine—Alzheimer's disease	0.00163	0.00364	CcSEcCtD
Alfentanil—Hypersensitivity—Donepezil—Alzheimer's disease	0.0016	0.00358	CcSEcCtD
Alfentanil—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00159	0.00356	CcSEcCtD
Alfentanil—Urticaria—Memantine—Alzheimer's disease	0.00157	0.00351	CcSEcCtD
Alfentanil—Body temperature increased—Memantine—Alzheimer's disease	0.00156	0.00349	CcSEcCtD
Alfentanil—Asthenia—Donepezil—Alzheimer's disease	0.00156	0.00349	CcSEcCtD
Alfentanil—Pruritus—Donepezil—Alzheimer's disease	0.00154	0.00344	CcSEcCtD
Alfentanil—Urticaria—Rivastigmine—Alzheimer's disease	0.00153	0.00343	CcSEcCtD
Alfentanil—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00153	0.00341	CcSEcCtD
Alfentanil—Hypersensitivity—Memantine—Alzheimer's disease	0.00145	0.00325	CcSEcCtD
Alfentanil—Dizziness—Donepezil—Alzheimer's disease	0.00144	0.00322	CcSEcCtD
Alfentanil—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00142	0.00318	CcSEcCtD
Alfentanil—Asthenia—Memantine—Alzheimer's disease	0.00142	0.00317	CcSEcCtD
Alfentanil—Pruritus—Memantine—Alzheimer's disease	0.0014	0.00312	CcSEcCtD
Alfentanil—Asthenia—Rivastigmine—Alzheimer's disease	0.00139	0.0031	CcSEcCtD
Alfentanil—Vomiting—Donepezil—Alzheimer's disease	0.00138	0.00309	CcSEcCtD
Alfentanil—Rash—Donepezil—Alzheimer's disease	0.00137	0.00307	CcSEcCtD
Alfentanil—Dermatitis—Donepezil—Alzheimer's disease	0.00137	0.00306	CcSEcCtD
Alfentanil—Pruritus—Rivastigmine—Alzheimer's disease	0.00137	0.00306	CcSEcCtD
Alfentanil—Headache—Donepezil—Alzheimer's disease	0.00136	0.00305	CcSEcCtD
Alfentanil—Dizziness—Memantine—Alzheimer's disease	0.00131	0.00292	CcSEcCtD
Alfentanil—Nausea—Donepezil—Alzheimer's disease	0.00129	0.00289	CcSEcCtD
Alfentanil—Dizziness—Rivastigmine—Alzheimer's disease	0.00128	0.00286	CcSEcCtD
Alfentanil—Vomiting—Memantine—Alzheimer's disease	0.00126	0.00281	CcSEcCtD
Alfentanil—Rash—Memantine—Alzheimer's disease	0.00124	0.00278	CcSEcCtD
Alfentanil—Dermatitis—Memantine—Alzheimer's disease	0.00124	0.00278	CcSEcCtD
Alfentanil—Headache—Memantine—Alzheimer's disease	0.00124	0.00277	CcSEcCtD
Alfentanil—Vomiting—Rivastigmine—Alzheimer's disease	0.00123	0.00275	CcSEcCtD
Alfentanil—Rash—Rivastigmine—Alzheimer's disease	0.00122	0.00272	CcSEcCtD
Alfentanil—Dermatitis—Rivastigmine—Alzheimer's disease	0.00122	0.00272	CcSEcCtD
Alfentanil—Headache—Rivastigmine—Alzheimer's disease	0.00121	0.00271	CcSEcCtD
Alfentanil—Nausea—Memantine—Alzheimer's disease	0.00117	0.00262	CcSEcCtD
Alfentanil—Nausea—Rivastigmine—Alzheimer's disease	0.00115	0.00257	CcSEcCtD
Alfentanil—ALB—Metabolism—HSD17B10—Alzheimer's disease	8.02e-05	0.000614	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	8.01e-05	0.000613	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—APP—Alzheimer's disease	8.01e-05	0.000613	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	7.97e-05	0.00061	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	7.9e-05	0.000605	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.84e-05	0.0006	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.78e-05	0.000595	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	7.77e-05	0.000595	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP46A1—Alzheimer's disease	7.72e-05	0.000591	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	7.72e-05	0.000591	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CHAT—Alzheimer's disease	7.72e-05	0.000591	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TPI1—Alzheimer's disease	7.72e-05	0.000591	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	7.69e-05	0.000588	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	7.6e-05	0.000582	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	7.59e-05	0.000581	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	7.59e-05	0.000581	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ND1—Alzheimer's disease	7.46e-05	0.000571	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	7.41e-05	0.000567	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MAOB—Alzheimer's disease	7.4e-05	0.000566	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLD3—Alzheimer's disease	7.33e-05	0.000561	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	7.29e-05	0.000558	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	7.29e-05	0.000558	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	7.12e-05	0.000545	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	7.03e-05	0.000538	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—A2M—Alzheimer's disease	6.88e-05	0.000527	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.81e-05	0.000521	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	6.77e-05	0.000518	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	6.69e-05	0.000512	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.67e-05	0.00051	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	6.64e-05	0.000508	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.59e-05	0.000505	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ND1—Alzheimer's disease	6.53e-05	0.0005	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SOD1—Alzheimer's disease	6.53e-05	0.000499	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	6.48e-05	0.000496	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	6.3e-05	0.000482	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	6.25e-05	0.000478	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	6.25e-05	0.000478	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF2—Alzheimer's disease	6.2e-05	0.000474	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.12e-05	0.000468	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	5.99e-05	0.000458	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ACHE—Alzheimer's disease	5.99e-05	0.000458	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	5.96e-05	0.000456	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	5.93e-05	0.000453	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	5.92e-05	0.000453	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	5.85e-05	0.000448	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	5.75e-05	0.00044	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.75e-05	0.00044	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	5.67e-05	0.000434	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ENO1—Alzheimer's disease	5.61e-05	0.000429	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	5.61e-05	0.000429	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PRKCG—Alzheimer's disease	5.59e-05	0.000428	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TPI1—Alzheimer's disease	5.58e-05	0.000427	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CHAT—Alzheimer's disease	5.58e-05	0.000427	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	5.55e-05	0.000425	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	5.5e-05	0.000421	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	5.45e-05	0.000417	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.44e-05	0.000416	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	5.43e-05	0.000415	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.38e-05	0.000412	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	5.36e-05	0.00041	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MAOB—Alzheimer's disease	5.35e-05	0.000409	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	5.35e-05	0.000409	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA4—Alzheimer's disease	5.31e-05	0.000407	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.23e-05	0.0004	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—BCHE—Alzheimer's disease	5.21e-05	0.000399	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	5.2e-05	0.000398	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SST—Alzheimer's disease	5.2e-05	0.000398	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	5.2e-05	0.000398	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	5.18e-05	0.000396	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	5.16e-05	0.000395	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	5.15e-05	0.000394	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APP—Alzheimer's disease	5.07e-05	0.000388	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	5.04e-05	0.000386	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.99e-05	0.000382	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—A2M—Alzheimer's disease	4.97e-05	0.000381	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.97e-05	0.00038	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	4.92e-05	0.000377	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PLAU—Alzheimer's disease	4.89e-05	0.000374	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	4.87e-05	0.000373	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CALM1—Alzheimer's disease	4.83e-05	0.00037	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TPI1—Alzheimer's disease	4.81e-05	0.000368	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CHAT—Alzheimer's disease	4.81e-05	0.000368	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	4.78e-05	0.000366	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CAV1—Alzheimer's disease	4.77e-05	0.000365	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	4.77e-05	0.000365	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.77e-05	0.000365	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.73e-05	0.000362	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	4.63e-05	0.000354	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MAOB—Alzheimer's disease	4.61e-05	0.000353	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.56e-05	0.000349	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—F2—Alzheimer's disease	4.54e-05	0.000348	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.52e-05	0.000346	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—Alzheimer's disease	4.49e-05	0.000343	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	4.46e-05	0.000342	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	4.44e-05	0.000339	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GAPDH—Alzheimer's disease	4.44e-05	0.000339	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.39e-05	0.000336	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	4.36e-05	0.000334	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.34e-05	0.000332	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	4.34e-05	0.000332	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.33e-05	0.000331	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ACHE—Alzheimer's disease	4.33e-05	0.000331	CbGpPWpGaD
Alfentanil—ALB—Metabolism—A2M—Alzheimer's disease	4.28e-05	0.000328	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	4.28e-05	0.000327	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.26e-05	0.000326	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CHAT—Alzheimer's disease	4.21e-05	0.000322	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TPI1—Alzheimer's disease	4.21e-05	0.000322	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	4.17e-05	0.000319	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	4.12e-05	0.000315	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	4.11e-05	0.000315	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	4.09e-05	0.000313	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ENO1—Alzheimer's disease	4.05e-05	0.00031	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	4.05e-05	0.00031	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MAOB—Alzheimer's disease	4.04e-05	0.000309	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ND1—Alzheimer's disease	4.03e-05	0.000308	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF1—Alzheimer's disease	3.98e-05	0.000305	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	3.98e-05	0.000304	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	3.93e-05	0.0003	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GAPDH—Alzheimer's disease	3.89e-05	0.000297	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.82e-05	0.000292	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	3.8e-05	0.00029	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—BCHE—Alzheimer's disease	3.77e-05	0.000288	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—A2M—Alzheimer's disease	3.75e-05	0.000287	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.75e-05	0.000287	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—LPL—Alzheimer's disease	3.74e-05	0.000286	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ACHE—Alzheimer's disease	3.73e-05	0.000285	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INPP5D—Alzheimer's disease	3.68e-05	0.000282	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	3.64e-05	0.000278	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS3—Alzheimer's disease	3.61e-05	0.000276	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	3.61e-05	0.000276	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	3.56e-05	0.000272	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	3.54e-05	0.000271	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO1—Alzheimer's disease	3.49e-05	0.000267	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS1—Alzheimer's disease	3.49e-05	0.000267	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	3.45e-05	0.000264	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	3.45e-05	0.000264	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2D6—Alzheimer's disease	3.42e-05	0.000262	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	3.37e-05	0.000258	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.35e-05	0.000257	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.28e-05	0.000251	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ACHE—Alzheimer's disease	3.26e-05	0.00025	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BCHE—Alzheimer's disease	3.25e-05	0.000248	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INPP5D—Alzheimer's disease	3.23e-05	0.000247	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	3.22e-05	0.000246	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.17e-05	0.000242	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CALM1—Alzheimer's disease	3.15e-05	0.000241	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—Alzheimer's disease	3.14e-05	0.00024	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAV1—Alzheimer's disease	3.11e-05	0.000238	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLCB1—Alzheimer's disease	3.06e-05	0.000234	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	3.06e-05	0.000234	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO1—Alzheimer's disease	3.06e-05	0.000234	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS1—Alzheimer's disease	3.06e-05	0.000234	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	3.05e-05	0.000233	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	3.05e-05	0.000233	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	3.02e-05	0.000231	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3e-05	0.00023	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3e-05	0.00023	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.97e-05	0.000227	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCA1—Alzheimer's disease	2.97e-05	0.000227	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.96e-05	0.000226	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.91e-05	0.000223	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2—Alzheimer's disease	2.88e-05	0.00022	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.84e-05	0.000218	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.81e-05	0.000215	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—Alzheimer's disease	2.73e-05	0.000209	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LPL—Alzheimer's disease	2.71e-05	0.000207	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.68e-05	0.000205	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INS—Alzheimer's disease	2.68e-05	0.000205	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.64e-05	0.000202	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.62e-05	0.000201	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INS—Alzheimer's disease	2.61e-05	0.000199	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.6e-05	0.000199	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—Alzheimer's disease	2.6e-05	0.000199	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.59e-05	0.000199	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.59e-05	0.000199	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.56e-05	0.000196	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARGC1A—Alzheimer's disease	2.56e-05	0.000196	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—Alzheimer's disease	2.55e-05	0.000195	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.52e-05	0.000193	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.49e-05	0.00019	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.44e-05	0.000186	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.39e-05	0.000183	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—Alzheimer's disease	2.39e-05	0.000183	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—Alzheimer's disease	2.35e-05	0.00018	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LPL—Alzheimer's disease	2.33e-05	0.000178	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.31e-05	0.000177	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.28e-05	0.000175	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.28e-05	0.000174	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.27e-05	0.000174	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.25e-05	0.000172	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.24e-05	0.000172	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.23e-05	0.000171	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	2.15e-05	0.000164	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—Alzheimer's disease	2.1e-05	0.000161	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LPL—Alzheimer's disease	2.04e-05	0.000156	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.01e-05	0.000154	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.99e-05	0.000152	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.98e-05	0.000151	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—Alzheimer's disease	1.96e-05	0.00015	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CALM1—Alzheimer's disease	1.96e-05	0.00015	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.96e-05	0.00015	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—Alzheimer's disease	1.95e-05	0.000149	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.94e-05	0.000148	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INS—Alzheimer's disease	1.94e-05	0.000148	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAV1—Alzheimer's disease	1.93e-05	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.93e-05	0.000147	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.88e-05	0.000144	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.88e-05	0.000144	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.85e-05	0.000141	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.84e-05	0.000141	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.78e-05	0.000136	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.78e-05	0.000136	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.75e-05	0.000134	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.72e-05	0.000131	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—Alzheimer's disease	1.71e-05	0.000131	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—Alzheimer's disease	1.7e-05	0.00013	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.7e-05	0.00013	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.7e-05	0.00013	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INS—Alzheimer's disease	1.67e-05	0.000128	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—Alzheimer's disease	1.66e-05	0.000127	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.65e-05	0.000127	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-05	0.000126	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.6e-05	0.000123	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.55e-05	0.000119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-05	0.000116	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.49e-05	0.000114	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—Alzheimer's disease	1.46e-05	0.000112	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INS—Alzheimer's disease	1.46e-05	0.000112	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.38e-05	0.000106	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.38e-05	0.000105	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—Alzheimer's disease	1.34e-05	0.000102	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.28e-05	9.81e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.26e-05	9.62e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	1.24e-05	9.52e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.17e-05	8.97e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	1.14e-05	8.71e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.13e-05	8.67e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.08e-05	8.27e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.06e-05	8.1e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.05e-05	8.07e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-05	8.04e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.04e-05	7.99e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.18e-06	7.03e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INS—Alzheimer's disease	9.01e-06	6.89e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.9e-06	6.04e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.81e-06	5.98e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.22e-06	5.53e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—Alzheimer's disease	6.73e-06	5.15e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.89e-06	4.51e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.63e-06	2.78e-05	CbGpPWpGaD
